New Delhi, Feb. 27 -- The Supreme Court on Tuesday restrained Patanjali Ayurved Ltd from issuing misleading advertisements on medical efficacy of its products and issued contempt notices to the company and its director Acharya Balakrishna for violating an earlier undertaking given in November.

A bench of justices Hima Kohli and Ahsanuddin Amanullah passed the order after being shown material by the Indian Medical Association (IMA), which first approached it in 2022, seeking action against Patanjali for disparaging modern medicine and making misleading claims about curing diseases, contrary to law.

"You are a person who can do anything. That's what we get from looking at these advertisements. The fact remains that you are selling your pr...